ATOS   $1.445  -0.69% Market Open

Atossa Therapeutics Inc
Total Cash 79.53M
totalCashPerShare 0.632
EBITDA -30.55M
Total Debt 0.00
quickRatio 13.962
currentRatio 14.347
Total Revenue
debtToEquity
Revenue/Share
ROA -0.19677
ROE -0.28004998
grossProfits
freeCashflow -10.24M
operatingCashflow -18.68M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 111.63M
forwardPE -5.629629
floatShares 117.92M
sharesOutstanding 125.76M
sharesShort 12.90M
sharesShortPriorMonth 12.72M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.27%
Short Ratio help_outline 21.85%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 0.637
Price To Book help_outline 2.39
earningsQuarterlyGrowth
netIncomeToCommon -25.91M
trailingEps -0.21%
forwardEps -0.27%
enterpriseToEbitda -3.65
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.06 3Q 2024
institutionsCount 100
lastUpdated Sept. 16, 2024, 12:35 p.m.